外泌体治疗糖尿病足溃疡方法探索
Exploration of Exosome Therapy for Diabetic Foot Ulcer
DOI: 10.12677/acm.2024.1461925, PDF,    科研立项经费支持
作者: 赖舒畅, 琚 枫, 陈清华, 邓文艺, 陈宗存, 符茂雄*:海南医科大学第二附属医院内分泌科,海南 海口
关键词: 外泌体糖尿病足载体Exosomes Diabetic Foot Carrier
摘要: 背景:外泌体(Exosomes),可由多种类型的细胞分泌的多泡内涵体,通过与细胞膜的融合将其中的递质转移到另一细胞,从而实现跨细胞信息传递并调节胞间信号传导,发挥多种生物学功能。外泌体在组织修复中具有优秀的效果。然而外泌体的临床应用也存在着一定的问题,一方面,靶向性不足;另一方面,外泌体外用存在效果不佳,失效的速度快的特点。在此,我们寻找到一种合适的载体对外泌体进行靶向增强以及延长作用时间。本文对我们所使用的研究方法进行简要阐述,以期为相关的研究提供一定的参考及借鉴。
Abstract: Background: Exosomes are multivesicular endosomes secreted by various types of cells, which transfer the transmitters to another cell through fusion with the cell membrane, thus achieving transcellular information transmission and regulating intercellular signal transduction, thus playing a variety of biological functions. Exosomes have excellent effects in tissue repair. However, there are some problems in the clinical application of exosomes. On the one hand, the targeting is insufficient; on the other hand, in vitro application of exotin has the characteristics of poor effect and fast failure rate. Here, we find a suitable vector for targeted enhancement of exosomes and prolonging the action time. This article briefly elaborates on the research methods we use, in order to provide some reference and inspiration for related research.
文章引用:赖舒畅, 琚枫, 陈清华, 邓文艺, 陈宗存, 符茂雄. 外泌体治疗糖尿病足溃疡方法探索[J]. 临床医学进展, 2024, 14(6): 1381-1387. https://doi.org/10.12677/acm.2024.1461925

参考文献

[1] Mishra, S.C., Chhatbar, K.C., Kashikar, A. and Mehndiratta, A. (2017) Diabetic Foot. BMJ, 359, j5064. [Google Scholar] [CrossRef] [PubMed]
[2] Armstrong, D.G., Tan, T., Boulton, A.J.M. and Bus, S.A. (2023) Diabetic Foot Ulcers. JAMA, 330, 62-75. [Google Scholar] [CrossRef] [PubMed]
[3] Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B.B., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice, 183, Article ID: 109119. [Google Scholar] [CrossRef] [PubMed]
[4] Al-Maskari, F., El-Sadig, M. and Nagelkerke, N. (2010) Assessment of the Direct Medical Costs of Diabetes Mellitus and Its Complications in the United Arab Emirates. BMC Public Health, 10, Article No. 679. [Google Scholar] [CrossRef] [PubMed]
[5] Yu, Q., Qiao, G., Wang, M., Yu, L., Sun, Y., Shi, H., et al. (2022) Stem Cell-Based Therapy for Diabetic Foot Ulcers. Frontiers in Cell and Developmental Biology, 10, Article 812262. [Google Scholar] [CrossRef] [PubMed]
[6] Nalisa, D.L., Moneruzzaman, M., Changwe, G.J., Mobet, Y., Li, L.P., Ma, Y.J., et al. (2022) Stem Cell Therapy for Diabetic Foot Ulcers: Theory and Practice. Journal of Diabetes Research, 2022, Article ID: 6028743. [Google Scholar] [CrossRef] [PubMed]
[7] Cao, Y., Yan, J., Dong, Z., Wang, J., Jiang, X., Cui, T., et al. (2023) Adipose-derived Mesenchymal Stem Cells Are Ideal for the Cell-Based Treatment of Refractory Wounds: Strong Potential for Angiogenesis. Stem Cell Reviews and Reports, 20, 313-328. [Google Scholar] [CrossRef] [PubMed]
[8] Ma, K., Luo, C., Du, M., Wei, Q., Luo, Q., Zheng, L., et al. (2024) Advances in Stem Cells Treatment of Diabetic Wounds: A Bibliometric Analysis via Citespace. Skin Research and Technology, 30, e13665. [Google Scholar] [CrossRef] [PubMed]
[9] Levy, D., Abadchi, S.N., Shababi, N., Ravari, M.R., Pirolli, N.H., Bergeron, C., et al. (2023) Induced Pluripotent Stem Cell‐Derived Extracellular Vesicles Promote Wound Repair in a Diabetic Mouse Model via an Anti‐inflammatory Immunomodulatory Mechanism. Advanced Healthcare Materials, 12, e2300879. [Google Scholar] [CrossRef] [PubMed]
[10] Yu, L., Qin, J., Xing, J., Dai, Z., Zhang, T., Wang, F., et al. (2023) The Mechanisms of Exosomes in Diabetic Foot Ulcers Healing: A Detailed Review. Journal of Molecular Medicine, 101, 1209-1228. [Google Scholar] [CrossRef] [PubMed]
[11] Merino-González, C., Zuñiga, F.A., Escudero, C., Ormazabal, V., Reyes, C., Nova-Lamperti, E., et al. (2016) Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Angiogenesis: Potencial Clinical Application. Frontiers in Physiology, 7, Article 24. [Google Scholar] [CrossRef] [PubMed]
[12] Peng, G.L. (2019) Platelet-rich Plasma for Skin Rejuvenation. Facial Plastic Surgery Clinics of North America, 27, 405-411. [Google Scholar] [CrossRef] [PubMed]
[13] Huber, S.C., de Moraes Martinelli, B., Quintero, M., de Paula, L.Í.S., Cataldo, J.L., de Lima Montalvão, S.A., et al. (2021) A Case Series of Platelet Rich Plasma in Chronic Venous Ulcers. Regenerative Therapy, 18, 51-58. [Google Scholar] [CrossRef] [PubMed]
[14] Li, W., Wang, Q., Bai, X. and Xu, J. (2022) Autologous Platelet-Rich Gel in the Treatment of Diabetic Foot Ulcers: A Retrospective Study. Medicine, 101, e31701. [Google Scholar] [CrossRef] [PubMed]
[15] Markov, A., Thangavelu, L., Aravindhan, S., Zekiy, A.O., Jarahian, M., Chartrand, M.S., et al. (2021) Retracted Article: Mesenchymal Stem/stromal Cells as a Valuable Source for the Treatment of Immune-Mediated Disorders. Stem Cell Research & Therapy, 12, Article No. 192. [Google Scholar] [CrossRef] [PubMed]
[16] Wu, X., Showiheen, S.A.A., Sun, A.R., et al. (2019) Exosomes Extraction and Identification. Methods in Molecular Biology, 2054, 81-91. [Google Scholar] [CrossRef] [PubMed]
[17] Bakadia, B.M., Qaed Ahmed, A.A., Lamboni, L., Shi, Z., Mutu Mukole, B., Zheng, R., et al. (2023) Engineering Homologous Platelet-Rich Plasma, Platelet-Rich Plasma-Derived Exosomes, and Mesenchymal Stem Cell-Derived Exosomes-Based Dual-Crosslinked Hydrogels as Bioactive Diabetic Wound Dressings. Bioactive Materials, 28, 74-94. [Google Scholar] [CrossRef] [PubMed]